Invention Grant
- Patent Title: Agent for treating or preventing cancer, and combination of RF pathway inhibitor and MEK inhibitor for treating or preventing cancer
-
Application No.: US17680972Application Date: 2022-02-25
-
Publication No.: US11925646B2Publication Date: 2024-03-12
- Inventor: Takako Ooshio , Masahiro Sonoshita , Satoshi Ichikawa , Yusuke Satoh , Kiyonaga Fujii
- Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY , Tsuzuki Educational Institute
- Applicant Address: JP Sapporo
- Assignee: NATIONAL UNIVERSITY CORP. HOKKAIDO UNIVERSITY,Tsuzuki Educational Institute
- Current Assignee: NATIONAL UNIVERSITY CORP. HOKKAIDO UNIVERSITY,Tsuzuki Educational Institute
- Current Assignee Address: JP Sapporo; JP Fukuoka
- Agency: MagStone Law, LLP
- Agent Enshan Hong
- Priority: JP 21029585 2021.02.26
- Main IPC: A61K31/525
- IPC: A61K31/525 ; A61P35/00
Abstract:
The present invention provides a method for treatment or prevention of cancer through novel action mechanism, namely, through inhibition of a riboflavin pathway. The method for treatment or prevention of cancer comprises administering an RF pathway inhibitor to a subject in need thereof.
Public/Granted literature
Information query
IPC分类:
